Slate Run Pharmaceuticals Provisional
FDA Flags (3)
Class III RecallMar 2026
Slate Run Pharmaceuticals
Eptifibatide Injection, 75 mg/100 mL vial for weight-adjusted bolus dosing, 1x100 mL Single-dose Vial, For Intravenous U
Classification: Class III
Class II RecallMar 2025
Slate Run Pharmaceuticals
Cinacalcet Hydrochloride Tablets 60 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 4321
Classification: Class II
Class II RecallMar 2025
Slate Run Pharmaceuticals
Cinacalcet Hydrochloride Tablets 30 mg, 30-count bottle, Rx only, Distr. by: Slate Run Pharma., LLC, Columbus, Ohio 4321
Classification: Class II